Global IV Therapy Market, Part 2 (2)

Part
01
of one
Part
01

Global IV Therapy Market, Part 2 (2)

Key Takeaways

Introduction

This report presents five top competitors in the global IV therapy market, which are Fresenius Se & co. KGAA, Pfizer Inc., Becton, Dickinson and Company, Terumo Medical Corporation, and B. Braun. Some information, especially the company's overview, has been provided verbatim.

Top Competitors in the Global Intravenous (IV) Therapy Market

1. Fresenius Se & co. KGAA

  • The website of Fresenius Se & co. KGAA can be accessed via this link. The company is headquartered in Bad Homburg, Germany.
  • Fresenius Se & co. KGAA is a global healthcare group that offers "high-quality products and services for dialysis, hospitals, and outpatient treatment." Fresenius Kabi is a subsidiary of Fresenius Se & co. KGAA health care group, which supplies drugs, clinical nutrition products, medical devices, and services to critically and chronically ill patients.
  • According to MarketWatch, Fresenius Se & co. KGAA is an industry leader owing to its significant revenue share. It generated £36,277 million in 2020.
  • Fresenius Se & co. KGAA offers innovative IV bags (Freeflex) for "leak prevention, sterility protection, and needle-stick prevention." The company also sells base solutions products such as 0.9% Sodium Chloride Injection, USP, 5% Dextrose Injection, USP, Lactated Ringer’s Injection, USP, and 0.45% Sodium Chloride Injection, USP, among others.
  • Some of the company's products for intravenous use include Perikabiven (Amino acids, electrolytes, dextrose, and lipid injectable emulsion) and Kabiven (Amino acids, electrolytes, dextrose, and lipid injectable emulsion).

2. Pfizer Inc.

3. Becton, Dickinson and Company

  • Becton, Dickinson and Company is a global medical technology company that provides "innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes." The company's official website can be accessed here.
  • According to MarketWatch, Becton, Dickinson and Company is an industry leader owing to its significant revenue share. In 2020, its revenue amounted to $17,117 million.
  • Becton, Dickinson and Company provides IV solutions (IV fluids) including "pumps, software, interoperability, and vascular access devices and accessories" to improve patients' safety. The company offers needle-free systems & connectors and dedicated disposables.

4. Terumo Medical Corporation

5. B. Braun

Research Strategy

For this research on five top competitors in the global IV therapy market, we leveraged the most reputable sources of information available in the public domain, including MarketWatch, annual reports, catalogue/product pages, LinkedIn, and third-party sources such as Growjo, among others. We relied on experts' opinion to determine the "Top" competitors, which were major market players with significant revenue share. More to that, some information, especially the company's overview, has been provided verbatim and the revenues' currencies were not converted. Notably, Fresenius Kabi is a subsidiary of Fresenius Se & co. KGAA health care group, which supplies drugs, clinical nutrition products, medical devices, and services to critically and chronically ill patients; hence, we listed some service offerings by Fresenius Kabi.

Research proposal:

Only the project owner can select the next research path.
Need related research? Let's launch your next project!
Sources
Sources